English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Background 3,4-Methylenedioxymethamphetamine (MDMA or ‘ecstasy’) tablets are frequently contaminated by 4-MTA (‘flatliner’), an amphetamine derivative which is known to induce severe human intoxication and even death. Although an equipotent inducer of SERT-dependent 5-HT release in vivo, 4-MTA does not induce MDMAlike serotoninergic neurotoxicity in rats. Instead, 4-MTA users typically report unpleasant sympathomimetic effects such as tachycardia, tremors, stomach cramps, headache and sweating following ingestion. Here, for the first time we investigate the cytotoxic potency of 4-MTA in a catecholaminergic system.

4-Methylthioamphetamine (4-MTA) induces mitochondrial-dependent apoptosis in SH-SY5Y cells independently of dopamine and noradrenaline transporters